Pharmaceuticals
10 AbbVie business development leaders
These ten current and former AbbVie business development leaders have held director, senior director, executive director, head and vice president roles in business development and acquisitions, licensing, search and evaluation and global alliances at AbbVie. A reader can learn how business development leaders work at AbbVie from people who have held the role.
Professionals to explore
01—10Andrei Cervoneascii
LinkedInExperience: Executive Director, Business Development & Acquisitions · AbbVie
Executive Director, Business Development & Acquisitions at AbbVie since May 2020, based in New York. His profile says he is responsible for commercial assessments supporting global licensing and acquisitions across the eye care and ophthalmology therapeutic areas.
Anthony Brazda
LinkedInExperience: Senior Director, Licensing and Acquisitions · AbbVie
Senior Director, Licensing and Acquisitions at AbbVie since April 2016, after serving as Director, Licensing & Acquisitions (2013–2016) and Senior Manager, Business Development at AbbVie. Before AbbVie he was a Senior Manager in business development and a product manager at Abbott.
Jeremy L. Schieler
LinkedInExperience: Director, Global Alliances · AbbVie
Director, Global Alliances at AbbVie since September 2024, in general management at director level. He previously held Director (2023–2024), Associate Director (2021–2023) and Senior Manager (2019–2021) roles in AbbVie's Technology Licensing & Collaborations group, and earlier was Manager, Non-Clinical Strategic Sourcing at AbbVie.
Joachim Vogt
LinkedInExperience: Director, Search and Evaluation International · AbbVie
Director, Search and Evaluation International at AbbVie since September 2018, based in Ludwigshafen, Germany. He was previously Director Global Business Development – Early Stage Partnering at Roche (2016–2018); his profile lists business development experience across oncology, immunology, rare diseases, gene therapy and platform technologies.
John FitzGerald
LinkedInExperience: Senior Director, Licensing & Acquisitions · AbbVie
Former Senior Director, Licensing & Acquisitions at AbbVie (2013–2018 and 2020–2025), with a stint as Senior Director, Venture Capital at AbbVie in between (2018–2020). Before AbbVie he was Senior Director, Licensing & Acquisitions at Abbott from 2001 to 2012, after international marketing and finance roles there.
Michelle Parks
LinkedInExperience: Head, Technology Licensing & Collaborations · AbbVie
Head, Technology Licensing & Collaborations at AbbVie since June 2014, at director level, and Head, Business Partnering - R&D Procurement since August 2025. She was earlier Director, Technology Licensing in AbbVie's licensing and acquisitions group and worked in business development at Abbott from 2000 to 2012.
Rachel Zimet Strick
LinkedInExperience: VP Business Development & Acquisitions Immunology, Specialty, Eye Care and Platforms · AbbVie
VP Business Development & Acquisitions Immunology, Specialty, Eye Care and Platforms at AbbVie since July 2024; her profile describes leading global business development deals across a wide variety of deal structures. She was Head of Immunology Business Development & Acquisitions (2022–2024) and earlier held senior director and director licensing roles at AbbVie.
Rahul Jerath
LinkedInExperience: Senior Director, Head of Oncology Business Development & Acquisitions · AbbVie
Senior Director, Head of Oncology Business Development & Acquisitions at AbbVie since October 2016; his profile describes target selection, diligence, valuation and negotiations to close biopharma deals. He was earlier Senior Director, Business Development and Licensing, M&A at Baxalta and Director, Business Development at Baxter International.
Sridhar Gopal
LinkedInExperience: Head Of International Business Development · AbbVie
Head Of International Business Development at AbbVie since April 2020; his profile describes heading M&A, in- and out-licensing and business development for AbbVie's international business. He earlier led business development for Japan, emerging markets and Australia at AbbVie, and held transaction and regional BD roles at AstraZeneca.
Zohaib Saeed
LinkedInExperience: Director II, Business Development and Acquisitions · AbbVie
Director II, Business Development and Acquisitions at AbbVie since April 2025. He was previously Director of Acquisitions, Global Business Development - Oncology, CNS, and IDV at Johnson & Johnson (2022–2025), and before that worked in business development transactions at Bristol Myers Squibb and search and evaluation at Celgene.
Choose the right perspective
Match the person's scope to your question, since therapeutic-area deal teams, international business development, search and evaluation, technology licensing and alliance management involve different work. Check whether the person's role is current or former and which therapeutic area or region it covers, since both shape what they can speak to.
Questions to take into the conversation
- 01How does a large pharmaceutical company organize business development by therapeutic area?
- 02How are commercial assessments used when evaluating a licensing or acquisition target?
- 03How does business development work differ for international markets compared with the US?
Reaching AbbVie business development leaders
How can I contact one of these AbbVie business development leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: AbbVie, based on profile data retrieved on October 9, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach AbbVie business development leaders?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these AbbVie business development leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal